859825-79-9

Basic information

• Product Name: 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine
• Synonyms: 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine
• CAS NO: 859825-79-9
• Molecular Formula: C₁₄H₁₅ClN₄
• Molecular Weight: 274.75
• Product Categories: CHIRAL CHEMICALS
• Mol File: 859825-79-9.mol

Chemical Properties

• Boiling Point: 478.8 °C at 760 mmHg
• Flash Point: 243.3 °C
• Appearance: /
• Density: 1.331 g/cm³
• Vapor Pressure: 2.5E-09mmHg at 25°C
• Refractive Index: 1.663
• Storage Temp.: 2-8°C
• PKA: 5.10±0.20(Predicted)
• CAS DataBase Reference: 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine(859825-79-9)
• EPA Substance Registry System: 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine(859825-79-9)

Safety Data

• Hazardous Substances Data: 859825-79-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
7-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine is used as a potential pharmaceutical candidate for [specific application reason] due to its heterocyclic structure and amine functional group. The benzyl and chlorine substituents may enhance its reactivity and interactions with biological targets, making it a promising compound for drug development.
Used in Chemical Research:
7-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine is used as a subject of chemical research to explore its properties, reactivity, and potential applications. 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine's unique structure and functional groups provide opportunities for studying its behavior in various chemical reactions and interactions.
Note: The specific application reason in the pharmaceutical industry and other potential uses are not provided in the given materials. Further research and information are needed to accurately list the uses of 7-benzyl-4-chloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine.

InChI:InChI=1/C14H15ClN4/c15-13-11-6-7-19(8-10-4-2-1-3-5-10)9-12(11)17-14(16)18-13/h1-5H,6-9H2,(H2,16,17,18)

Upstream product

• 52763-21-0 ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride 
• 62458-92-8 2-amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-ol 
• 62458-92-8 2-amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(4aH)-one 

Downstream Products

• 1449500-11-1 (2-amino-4-(butylamino)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)(phenyl)methanone 
• 1449500-86-0 7-benzyl-N⁴-butyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-2,4-diamine 
• 859825-81-3 C₂₁H₂₀F₃N₅ 
• 1449500-87-1 C₃₃H₄₉N₅O₆ 

Relevant articles and documents

HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE

The application is directed to compounds of formulae (IA) and (IB) and their salts and solvates, wherein R1a, R2a, R3a, A1, A2, A3, R1b, R2b, R3b, B1, and B2 are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., lysosomal storage diseases, such as Gaucher's disease, and α-synucleinopathies, such as Parkinson's disease.

Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists

In a continuing effort to discover novel TLR agonists, herein we report on the discovery and structure–activity relationship of novel tetrahydropyridopyrimidine TLR 7/8 agonists. Optimization of this series towards dual agonist activity and a high clearance profile resulted in the identification of compound 52a1. Evaluation in vivo revealed an interferon stimulated response (ISG) in mice with limited systemic exposure and demonstrated the potential in antiviral treatment or as a vaccine adjuvant.

P2X7 MODULATORS

The present invention is directed to a compound of Formula (I) The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

Piperidino-pyrimidine derivatives for the treatment of viral infections

This invention relates to piperidino-pyhmidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.

PIPERIDINO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

This invention relates to piperidino-pyhmidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.

BICYCLOHETEROARYLAMINE COMPOUNDS AS ION CHANNEL LIGANDS AND USES THEREOF

Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, includin

Rho-kinase inhibitors

Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., c